A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Arvinas, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 9,806 shares of ARVN stock, worth $265,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,806
Previous 9,806 -0.0%
Holding current value
$265,840
Previous $404,000 35.4%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $356,742 - $512,951
9,806 New
9,806 $404,000
Q1 2023

May 11, 2023

SELL
$26.15 - $37.26 $23,221 - $33,086
-888 Reduced 4.46%
19,010 $519,000
Q4 2022

Feb 08, 2023

SELL
$32.47 - $57.24 $37,405 - $65,940
-1,152 Reduced 5.47%
19,898 $681,000
Q3 2021

Nov 10, 2021

BUY
$73.2 - $107.87 $636,986 - $938,684
8,702 Added 70.47%
21,050 $1.75 Million
Q2 2021

Aug 10, 2021

BUY
$60.45 - $84.26 $746,436 - $1.04 Million
12,348 New
12,348 $952,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.44B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.